Global Automated DNA Sequencers Market: Overview
The increasing prevalence of genetic diseases across the world is the influencing the global market for automated DNA sequencers substantially. The increasing demand for demand for development of biological and personalized therapies is another important factor that has been reflecting greatly on this market. Going forward, the global market is likely to gain substantially from the constant advancements in genetic technology in the years to come. The increasing investments by public and private companies across industries, such as pharmaceuticals, biotechnology, agriculture, and food and beverages, are also projected to support the growth of this market over the next few years. This report is aimed at offering a thoroughly analyzed study of the global market for automated DNA sequencers, emphasizing on the growth drivers, obstructions, opportunities, challenges, market trends, and future potentials.
Global Automated DNA Sequencers Market: Trends and Opportunities
Sanger sequencing and next-generation sequencing have surfaced as the key sequencing method applied by automated DNA sequencers. Next-generation sequencing method is more popular among these sequencers as, by this, large fragments of DNA can be analyzed with high throughput and effectiveness. Researchers expect this trend to remain same over the forthcoming years.
Automated DNA sequencers find a widespread application in the pharmaceutical and biotechnology industries and a number of academic research institutes. Hospitals and diagnostic laboratories, environment-related industries, and government agencies are also report a high demand for these sequencers across the world.
Global Automated DNA Sequencers Market: Regional Outlook
In terms of the geography, the global market for automated DNA sequencers registers its existence across North America, Asia Pacific, Europe, and the Rest of World. North America has been leading the global market, thanks to the high uptake of technology and the increasing expenditure on research and development by public and private companies in this region. This regional market is anticipated to continue on the top position over the next few years. Europe, which currently holds the second position, is projected to retain its position in the near future, thanks to the presence of well-established pharmaceutical and biotechnology industry, here.
Companies Mentioned in the Report
The presence of a massive pool of international as well as local participants have made the global market for automated DNA sequencers fragmented and highly competitive. Some of the key vendors of automated DNA sequencers across the world are Illumina Inc., Siemens AG, GE Healthcare, Agilent Technologies, Oxford Nanopore Technologies Ltd., Life Technologies, and F. Hoffmann-La Roche Ltd.
Market segmentation based on geography:
- North America
- South America
- Asia Pacific
- Middle East and Africa
This report gives access to decisive data, such as:
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for the coming years
Key highlights of this report include:
- Overview of key market forces propelling and restraining market growth
- Up-to-date analyses of market trends and technological improvements
- Pin-point analyses of market competition dynamics to offer you a competitive edge
- An analysis of strategies of major competitors
- An array of graphics and SWOT analysis of major industry segments
- Detailed analyses of industry trends
- A well-defined technological growth map with an impact-analysis
- Offers a clear understanding of the competitive landscape and key product segments
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.